Mobile Site ›
Print Friendly View

Test ID: JAK2V    
JAK2 V617F Mutation Detection, Varies

‹ Back to Hematology index

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Point Mutation Detection in DNA Using Quantitative Polymerase Chain Reaction (PCR)

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

JAK2 V617F Mutation Detection, V

Aliases Lists additional common names for a test, as an aid in searching

Janus kinase 2 gene Tyrosine kinase mutation
Tyrosine Kinase Mutation